Buprenorphine And Naloxone Tablet
Product Images NDC 31722-850

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 31722-850). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2mg-30s (2mg 30s)

Packaging label for Buprenorphine and Naloxone Sublingual Tablets, USP, 2 mg/0.5 mg strength. The label shows the product is manufactured by Ascent Pharmaceuticals, Inc. and labeled for Camber Pharmaceuticals, Inc. It includes a warning about accidental ingestion by children, dosage instructions directing to see package insert, and storage conditions. The package contains 30 tablets for sublingual use, with Rx only designation.*

FDA Label Image

8mg-30s (8mg 30s)

Packaging label for Buprenorphine and Naloxone Sublingual Tablets, USP, 8 mg/2 mg strength, by Camber Pharmaceuticals, Inc. The label states the product is Rx only and contains 30 tablets. It includes warnings about accidental ingestion by children and storage instructions. Manufactured by Ascent Pharmaceuticals and labeled for Camber Pharmaceuticals.*

FDA Label Image

Buprenorphine -structural Formula (Buprenorphine Structural Formula)

Chemical structure of Buprenorphine hydrochloride, showing its molecular arrangement including hydroxyl groups, methyl groups, cyclopropyl group, and hydrochloride moiety.*

FDA Label Image

Naloxone -structural Formula (Naloxone Structural Formula)

Chemical structure of Buprenorphine hydrochloride dihydrate showing its molecular framework with labeled functional groups and hydrated form (2 molecules of water).*

FDA Label Image

Spl-figure (Spl Figure)

An instructional black-and-white illustration showing a person placing a tablet under their tongue, depicting proper administration of a sublingual tablet.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.